We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yeah thats right watching.... what's your excuse?
If you believe I am paid then why don't you just filter me? why read anything I say? What reason could you give to monitor this BB 7 days a week.
It can't be what I post because I post a whole range of views. From TA (up or down as I think it will go), to potential explanations of the events as they unfold, so its not content.
So what, as you would say, sad, miserable boring life do you have that your only comment is to invent and make stuff up? Its nothing to do with AVCt when you religiously keep up this silly pointless and childish posts with absolutely no thought at all in what you are saying.
I guess you don't yet have the maturity to think very far ahead. Well hopefully that will come in time.
Soleboy, I don't disagree. It's possible he thought he could get this to FDA approval on his watch going alone (a big ambition and there is no issue with that if you play the game well enough) and therefore a possible reason no commercial team exists. Sadly relying on bucket shop brokers has cost him dearly in that plan as at every turn they have milked the placings and we have raised at lower levels. The lack of cornerstone investors another issue along that journey that would otherwise added some protection. He has done his best but now is time for a change. A big week ahead but the science is solid so it needs to get to market in the most advantageous way.
Written with AI. Assistance lol
Sunday double time Winne ?
How do we know AS is no good as a CEO?
We have zero info really, on how the company is financially run.
My beef (for a long time) was to me, (I stress the "me") the misleading info he has released on interviews. However I am also aware that he has little choice other than to paint a partial picture of exaggerating the positive and down playing or ignoring the negative aspects. The rounder picture is only revealed either way after the event, or through more intrusive questioning. As a results all of those Paul Hill Interviews to me looked scripted. Its why AVCT choose what questions are allowed in Q&A sections etc etc. But that is part of the job and does not reflect AVCT financial acumen (or not).
What if ....
What if the DX deals were actually a recognition of the opportunity of this fragmented huge market and these companies were/are undervalued and all they needed was extra resource and funding to get them to the next level? This would take capital investment, and added resources which AVCT have provided. Then all of a sudden the DX deals would look pretty savvy. An alternative might be the silence on this might be to have kept the valuation low, because the time for DX to be worth as a spin off, a reasonable amount was not going to come in time before more funding and AS hinted/mentioned/said/ that AVCT was valued too highly given the stage of where it was in its development.
Which gets us to the raise as the other contentious issue of his stewardship.
Some here did not see it coming but plenty did and I think so did the market. What I think took many more by surprise was the low price . This suggests that maybe AVCT were not in full control at that stage to be able to dictate terms in any meaningful way. I imagine this will not be the last raise (assuming there is no TO.) Therefore these funds may well be tapped again if they have kept their stock in the future, and they are building their stakes at effectively discounted prices. (The next raise can only come after yet more successful results). So they have a further de-risked proposition at, as I say, a discount to the market. That, if it was part of the deal, means that AVCT are looking 18-24 months ahead and would make sense of the don't worry about the funding remark, as he was not talking about this one but ultimately securing the future to keep AVCT independent to return max shareholder value.
I don't know if this musing has any validity, but as an alternative scenario it at least highlights our complete ignorance of actually what goes on behind the scenes and maybe we should not always rush and jump to conclusions when we should rather, admit our lack of knowledge a bout these matters.
On the other hand the BOD might well be, not up to the job......
Gsa will help close the gap by COB Monday
I reckon the 'funding to not be bothered about' was the sale of Dx, which then didn't happen in time.
Hi Oldt
I believe Alastair has had every opportunity to build a strong commercial team, unfortunately he has not done so to date. Given that we now have ‘proof of concept’ for pre|CISION surely the only explanation for the current valuation is the market has no confidence that Alastair can commercialise the technology. The events of the last year have given some justification to that view. You state he is not a good ceo. Surely we now need a strong experienced commercial ceo?
@Bella we already know AXA Farmington Biotech fund took part in the placing. This likely represents the 'European Healthcare fund'. I would love to see some of the names you mention also added especially the ones linked to EF. If they didn't take part I would want to know why. It seems AVCT has struggled to bolster the register in recent years but have the contacts on the board to change that. How much is the presence of DX potentially putting off investors?
Old trader. Hope you cast your vote accordingly at the AGM , I certainly will !
I agree although AS is not a good chief executive but he is a brilliant scientist and should STAY
Interesting article in the Times today, about Zandy Forbes, the eccentric CEO of MeiraGTx, another promising UK biotech. Her comments resonate here;
“Would she have floated on the LSE, if she had her time again? Absolutely not, she says. Small biotechs are risky, “money-burning endeavours,” she says. Meira, for example, invests in developing new medicines, but does not sell any treatments to patients yet.
While US pension funds and hedge funds have spent two decades gaining expertise in how to evaluate and invest in such drug developers, UK investors are simply not prepared to fund those risks.”
And as we’ve found out !
See the crayon munchers are turning positive and they're often right. Refreshing change from the relentless FUDsters.
Trails are modified by panels a lot outside control , and hope it’s all go from here.
Certainly the high FAP areas are responding .
We’ll see…
Yorkshire
OK then why has P1a gone on for so much longer than we were originally told it would? If as some say it was because Al wasn’t allowed to increase the dose in bigger steps then it can’t really be seen as Al’s fault.
What else is he guilty of? Even though it is a safety trial he obviously thought that the data was good enough to attract funding and I presume he was let down at the last minute and had to secure funding at a rock bottom price to continue a much longer clinical trial. Again I don’t see this as his fault. In terms of the ambiguous communications, it’s his job to paint as good a picture as possible. It will be disastrous if he is forced out.
Someone should tell GSA capital
Fancy the GAP above to close this week.
Ah, the "magic" RSI.....as indicators go its a bloody good one (imo)...
60.5 + achieved by 1/5/24
Tout, Chat relies on inputs and when this changes ,eg new info, thence all changes.
Last point on low FAP result being least efficacious, was expected.
& data on high FAP tumours represent a sig. result .
Any BP would be delighted to have this in their res portfolio at this stage.
I worked for this area so reflective experience.
Sad to see such bad rhetoric towards AS et al.
Undeserved UK Biotech support is NVG market wise , this is playing a big part here.
GLA on a cold Sunday morning. Now where’s the Yorkshire Gokd tea as?
RSI pivot divergence, time consumed projected forward predicts the sp, prediction of 60.5, will be achieved by 10/6/24. DYOR.
Positive divergence on RSI(relative strength index), suggests major sp, upside. The RSI, pivot low of 6/3/24, is used to compute the price fall to the recent RSI low, and the difference is added to the pivot price high of 6/3/24, to arrive at the projected future sp target of 60.5. No need to worry about overhead supply from previous trading, because price resistance is at higher level of 100. Underlying sector is bullish.
The post below gave me a ChatGPT analysis score of GENUINE 3
For once I agree with you - we don’t want change at the moment. I know Al hasn’t got total control over the clinical trials but I think he was far too slow in moving to a two week cycle when it was obvious that the target trial population was too broad. I think he believed that AVA6000 would perform well on lower FAP tumours and was caught off guard. Continuing to 7 rounds didn’t give him the results he needed to impress BP and he was forced into a fire sale fund raise.
All along he has been the king of ambiguous communications knowing that enough of us would read these in the most positive light.
If arm2 doesn’t yield the impressive results we need then Avacta might not get the opportunity to roll out what would’ve been a fantastic pipeline of life saving treatments.
i think it’s important to have someone at the helm who thinks in hundreds of millions and billions, and doesn’t go weak at the knees when a few million is bandied about. if we end up having change then the board must ensure that a new management teams incentives are aligned with medium to long term performance. i don’t want pumpers and bull****ters, it has to be solid commercially based incentive plans, looking at deals and revenue.
there also needs to be safeguards in place to ensure we don’t all get sold down the river with some contrived share giveaway, again the responsibility of the board.
It's sometime difficult to understand the motives of each post as there are emotions tied to some belief. But as we know we are bombarded with both Rampers and Drampers.
It might be useful to take an opinion from ChatGPT as a second opinion before getting into a ping-pong match.
Give ChatGPT a prompt and then paste the posting and allow ChatGPT to provide its opinion (not absolute truth but an opinion by AI).
So a prompt I used is :
"Prompt: I am on a bulletin board where people have the right to express their views on the company and the share price performance. There will be 3 types of posters: 1. Those who wish to ramp and hope that they can influence people to buy shares, 2. Those who wish to deramp and hope that they can influence people to sell shares and thereby drive the price down so that they can buy cheaper shares. 3. Those who are optimistic or pessimistic but have no agenda. For each post provide a score between 1 - 5 if they are a Ramper, DeRamper or Genuine. (You can choose your own prompt).
Results
For a random post that I inserted I got below results:
----------------------------------------
Scoring the Post
Ramper Score: 2
Reasoning: The post mentions potential buyout prices, which could be seen as mildly promotional by suggesting a significant upside potential without strong evidence. However, this seems more about illustrating a scenario rather than outright ramping.
DeRamper Score: 4
Reasoning: There's significant emphasis on the risks and limitations of waiting for FDA approval, suggesting that reliance on such an outcome is overly simplistic and risky. The poster uses a critical tone about the company’s strategy and the possible detachment of company leaders from shareholder interests. This could be seen as encouraging doubt and possibly selling shares out of caution or disillusionment.
Genuine Score: 3
Reasoning: The post presents a detailed analysis and includes various perspectives on the company's situation. It raises valid concerns about management and investment strategies which contribute to a broader conversation. However, the somewhat cynical view on company motives and the impact on private investors introduces bias that slightly undercuts its genuine nature.
Summary
This post leans towards being a "DeRamper" as it highlights the negatives and potential pitfalls of the current management and investment approach more than promoting the stock. It suggests skepticism about the current strategy's effectiveness and the company’s alignment with shareholder interests, which might influence readers towards a more cautious or negative view on holding the stock. The elements of genuine discussion are present but are overshadowed by the critical tone and the implications that management may not have the shareholders' best interests at heart.
Genstar
What have I said that runs contrary to the facts?